Press release
Golgi polarity shift instructs dendritic refinement in the neonatal cortex by mediating NMDA receptor signaling
Naoki Nakagawa, Takuji Iwasato
Cell Reports 2023 Jul 28 DOI:10.1016/j.celrep.2023.112843
Press release (In Japanese only)
EurekAlert! link about this artcle
Neurons are the cells that constitute neural circuits and use chemicals and electricity to receive and send messages that allow the body to do everything, including thinking, sensing, moving, and more. Neurons have a long fiber called an axon that sends information to the subsequent neurons. Information from axons is received by branch-like structures that fan out from the cell body, called dendrites.
Dendritic refinement is an important part of early postnatal brain development during which dendrites are tailored to make specific connections with appropriate axons. In a recently published paper, researchers present evidence showing how a mechanism within the neurons of a rodent involving the Golgi apparatus initiates dendritic refinement with the help of the neuronal activity received by a receptor of a neurotransmitter called N-methyl-D-aspartate-type glutamate receptor (NMDAR).
The paper was published in Cell Reports on July 28. Read more>
Figure: The image shows a spiny stellate neuron (magenta) and its Golgi apparatus (white) in the mouse barrel cortex at postnatal day 5. The study found that the Golgi apparatus shows a biased distribution in one side of the neuron only during the postnatal critical period of circuit reorganization. This lateral Golgi polarity instructs the direction in which the neuron expands its dendrites for establishing precise neuronal circuit.
Dysregulated TDP-43 proteostasis perturbs excitability of spinal motor neurons during brainstem-mediated fictive locomotion in zebrafish
Kazuhide Asakawa, Hiroshi Handa, Koichi Kawakami
evelopment, Growth & Differentiation 2023 July 15 DOI:10.1111/dgd.12879
Amyotrophic lateral sclerosis (ALS) is a debilitating disease that causes muscle weakness and eventually fatal paralysis. A major hallmark of ALS is the deposition of the aggregate form of TDP-43 protein in motor neurons, a type of nerve cell that directs muscle contractions. This motor neuron pathology can occur without genetic mutations in the coding sequence of the TDP-43-encoding gene TARDBP. Whether and how wild-type TDP-43 drives pathological changes in motor neurons remain largely unexplored.
In the present study, Asakawa and colleagues used calcium imaging to directly compare the neural activity of motor neurons with and without excessive TDP-43 protein during fictive locomotion. They found that excessive amounts of TDP-43 protein reduced the excitability of motor neurons (Figure). This finding suggests that the reduced excitability caused by excessive TDP-43 potentially contributes to asymptomatic pathological lesions of motor neurons and movement disorders in patients with ALS.
This work was published in the journal Development Growth & Differentiation on the 15th of July, 2023. The study was conducted by a collaborative research group comprising the National Institute of Genetics (Kazuhide Asakawa and Koichi Kawakami) and Tokyo Medical University (Hiroshi Handa).
This work was supported by the Nakabayashi Trust For ALS Research (K.A.), The Kato Memorial Trust For Nambyo Research (K.A.), Daiichi-Sankyo Foundation of Life Science (K.A.), Takeda Science Foundation (K.A.), KAKENHI grant numbers JP16K07045 (K.A.), JP19K06933 (K.A.), JP22H02958 (K.A.), JP23H04266 (K.A.), JP21H02463 (K.K.) and AMED-PRIME grant number JP23gm6410011h0003 (K.A.), and the National BioResource Project (NBRP) (K.K.).
Figure: Excessive amounts of TDP-43 protein reduce motor neuron excitability
NIG will be closed from August 15 to August 16, 2023 for summer holiday.
Thank you for your understanding and cooperation.
Efficient production of recombinant proteins in suspension CHO cells culture using the Tol2 transposon system coupled with cycloheximide resistance selection.
Keina Yamaguchi, Risa Ogawa, Masayoshi Tsukahara and Koichi Kawakami Scientific reports (2023) 13, 7628 DOI:10.1038/s41598-023-34636-4DNA recombination techniques in mammalian cells has been applied to the production of therapeutic proteins for several decades. To be used for commercial production, established cell lines should stably express target proteins with high productivity and acceptable quality for human use. In the conventional transfection method, the screening process is laborious and time-consuming since superior cell lines had to be selected from an enormous number of transfected cell pools and clonal cell lines with a wide variety of transgene insertion locations. In this study, we demonstrated that the combination of a Tol2 transposon system and cell selection by cycloheximide resistance is an efficient method to express therapeutic proteins, such as human antibody in suspension culture of Chinese hamster ovary cells. The resulting stable cell lines showed constant productivity and cell growth over long enough cultivation periods for recombinant protein production. We anticipate that this approach will prove widely applicable to protein production in research and development of pharmaceutical products.
Figure: Antibody productivity and cell growth of clonal cell lines 30-2-2, 30-2-10, 30-2-11 in the presence or absence of CHX selection. Antibody productivity (A, B and C), cell growth (D, E and F) and specific antibody productivity (pg/cell/day) (G, H and I) in 30-2-2, 30-2-10, 30-2-11 were measured in the presence (open circles) or absence (black circles) of CHX selection pressure.